Topoisomerase I inhibitors: camptothecins and beyond

Pommier, Yves
October 2006
Nature Reviews Cancer;Oct2006, Vol. 6 Issue 10, p789
Academic Journal
Nuclear DNA topoisomerase I (TOP1) is an essential human enzyme. It is the only known target of the alkaloid camptothecin, from which the potent anticancer agents irinotecan and topotecan are derived. As camptothecins bind at the interface of the TOP1–DNA complex, they represent a paradigm for interfacial inhibitors that reversibly trap macromolecular complexes. Several camptothecin and non-camptothecin derivatives are being developed to further increase anti-tumour activity and reduce side effects. The mechanisms and molecular determinants of tumour response to TOP1 inhibitors are reviewed, and rational combinations of TOP1 inhibitors with other drugs are considered based on current knowledge of repair and checkpoint pathways that are associated with TOP1-mediated DNA damage.


Related Articles

  • 3D-QSAR study of 20 ( S)-camptothecin analogs. Ai-jun Lu; Zhen-shan Zhang; Ming-yue Zheng; Han-jun Zou; Xiao-min Luo; Hua-liang Jiang // Acta Pharmacologica Sinica;Feb2007, Vol. 28 Issue 2, p307 

    Aim: To build up a quantitative structure-activity relationship (QSAR) model of 20 ( S)-camptothecin (CPT) analogs for the prediction of the activity of new CPT analogs for drug design. Methods: A training set of 43 structurally diverse CPT analogs which were inhibitors of topoisomerase I were...

  • Characterization of DNA Topoisomerase-1 in Spodoptera exigua for Toxicity Evaluation of Camptothecin and Hydoxy-Camptothecin. Zhang, Lan; Ma, Dejun; Zhang, Yanning; He, Weizhi; Yang, Jingjing; Li, Chuanren; Jiang, Hongyun // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Camptothecin (CPT), a plant alkaloid originally isolated from the native Chinese tree, Camptotheca acuminate, exerts the toxic effect by targeting eukaryotic DNA topoisomerase 1 (DNA Topo1). Besides as potent anti-cancer agents, CPT and its derivatives are now being explored as potential...

  • Topoisomerase I as a Biomarker: Detection of Activity at the Single Molecule Level. Proszek, Joanna; Roy, Amit; Jakobsen, Ann-Katrine; Frøhlich, Rikke; Knudsen, Birgitta R.; Stougaard, Magnus // Sensors (14248220);Jan2014, Vol. 14 Issue 1, p1195 

    Human topoisomerase I (hTopI) is an essential cellular enzyme. The enzyme is often upregulated in cancer cells, and it is a target for chemotherapeutic drugs of the camptothecin (CPT) family. Response to CPT-based treatment is dependent on hTopI activity, and reduction in activity, and mutations...

  • Camptothecin: Roles of the D and E Rings in Binding to the Topoisomerase I-DNA Covalent Binary Complex. Hecht, Sidney M. // Current Medicinal Chemistry - Anti-Cancer Agents;Jul2005, Vol. 5 Issue 4, p353 

    The alkaloid camptothecin is the prototypical DNA topoisomerase I poison. This core structure has formed the basis for two marketed antitumor agents and numerous clinical candidates, and has been the focus of many synthetic and medicinal chemistry studies. Recent reports have furthered our...

  • Molecular docking approach on the Topoisomerase I inhibitors series included in the NCI anti-cancer agents mechanism database. Antonino Lauria; Mario Ippolito; Anna Almerico // Journal of Molecular Modeling;Mar2007, Vol. 13 Issue 3, p393 

    Abstract??Topoisomerase I (Top1) is an essential enzyme participating to all those processes associated with separation of DNA strands. It manages superhelical tensions through the transient breakage of one strand of duplex DNA, followed by the unwinding of supercoiled DNA. Camptothecins, a...

  • Structural insights into CPT-11 activation by mammalian carboxylesterases. Bencharit, Sompop; Morton, Christopher L.; Howard-Williams, Escher L.; Danks, Mary K.; Potter, Philip M.; Redinbo, Matthew R. // Nature Structural Biology;May2002, Vol. 9 Issue 5, p337 

    Mammalian carboxylesterases cleave the anticancer prodrug CPT-11 (Irinotecan) into SN-38, a potent topoisomerase I poison, and 4-piperidino-piperidine (4PP). We present the 2.5 Ã… crystal structure of rabbit liver carboxylesterase (rCE), the most efficient enzyme known to activate CPT-11 in...

  • Transcriptomic and proteomic profiling of maize embryos exposed to camptothecin. Sánchez-Pons, Nuria; Irar, Sami; García-Muniz, Nora; Vicient, Carlos M. // BMC Plant Biology;2011, Vol. 11 Issue 1, p91 

    Background: Camptothecin is a plant alkaloid that specifically binds topoisomerase I, inhibiting its activity and inducing double stranded breaks in DNA, activating the cell responses to DNA damage and, in response to severe treatments, triggering cell death. Results: Comparative transcriptomic...

  • Metabolic and transcriptional analyses in response to potent inhibitors establish MEP pathway as major route for camptothecin biosynthesis in Nothapodytes nimmoniana (Graham) Mabb. Rather, Gulzar A.; Sharma, Arti; Jeelani, Syed Mudassir; Misra, Prashant; Kaul, Veenu; Lattoo, Surrinder K. // BMC Plant Biology;7/10/2019, Vol. 19 Issue 1, pN.PAG 

    Background: Nothapodytes nimmoniana, a plant of pivotal medicinal significance is a source of potent anticancer monoterpene indole alkaloid (MIA) camptothecin (CPT). This compound owes its potency due to topoisomerase-I inhibitory activity. However, biosynthetic and regulatory aspects of CPT...

  • Tyrosyl-DNA Phosphodiesterase 1 Targeting for Modulation of Camptothecin-Based Treatment. Beretta, G. L.; Cossa, G.; Gatti, L.; Zunino, F.; Perego, P. // Current Medicinal Chemistry;May2010, Vol. 17 Issue 15, p1500 

    The targeting of specific DNA repair mechanisms may be a promising strategy to improve the efficacy of antitumor therapy. The cytotoxic effects of the clinically relevant topoisomerase 1 (Top1) poison camptothecins are related to the generation of DNA lesions and tumor cells may be resistant to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics